JSPRW लाइव सिग्नल्स | Getagraph.com के साथ लाभ को अधिकतम करें

Live Chart Being Loaded With Signals

Commentary (26 Jun 2024 @ 19:00):
Our systems believe the stock currently is overvalued by -0.07% compare to its pairs and should correct downwards.

Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies...

Stats
आज की मात्रा	220
औसत मात्रा	0
बाजार मूल्य	322.78M
EPS	$-1.030 ( Q1 \| 2024-05-14 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.0500 (Sector) 42.63 (Industry) 24.32
ATR14	$0 (0.00%)

AADI -2.65%

ABCL 1.59%

ABCM 0.04%

ABEO -2.84%

ABIO -1.68%

ABOS 1.40%

ABSI 3.07%

ABUS -2.24%

ABVX -3.53%

ACAD -0.51%

ACER -17.95%

ACET -4.76%

ACGN 1.29%

ACHL -3.00%

ACHV -1.72%

ACIU -1.00%

ACLX -0.06%

ACRV -4.79%

ACST -1.63%

ACXP 0.65%

ADAG 4.64%

ADAP -2.91%

ADGI 0.87%

ADIL 0.54%

ADMA -2.72%

ADPT -0.30%

ADTX -3.47%

ADVM -4.34%

ADXN -1.60%

AEON -3.74%

AEZS -3.51%

AFMD -1.40%

AGEN -1.58%

AGIO -2.04%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW -13.88%

AKBA -3.39%

AKRO -2.81%

AKTX 4.08%

AKUS 0.00%

ALBO 0.00%

ALDX -2.26%

ALEC -3.90%

ALGS -2.41%

ALKS -0.19%

ALLK -8.47%

ALLO -6.39%

ALLR -3.17%

ALNA 3.16%

ALNY 1.77%

ALPN 0.02%

ALPX 0.00%

ALRN -0.34%

ALT -9.45%

ALVR -0.58%

ALXN 0.00%

ALXO -10.96%

ALZN 4.78%

AMRN -0.31%

AMTI -3.13%

ANAB 0.50%

ANEB -1.52%

ANGN 0.00%

ANIX -1.62%

ANL -6.60%

ANNX -0.63%

ANPC -3.15%

APGE -1.01%

APGN 8.48%

APGNW 30.65%

APLM 1.56%

APLS 0.00%

APLT -4.28%

APM -1.47%

APOP 0.38%

APRE 2.29%

APTO 3.27%

APTX 3.17%

APVO 0.18%

ARAV -13.39%

ARCT -3.84%

ARDS -14.23%

ARDX -0.66%

ARGX -0.81%

ARNA 0.00%

ARPO -0.90%

ARQT -0.57%

ARTL -2.50%

ARTLW 0.00%

ARVN 5.64%

ARWR -1.86%

ASLN -4.71%

ASMB -7.14%

ASND -0.91%

ATAI -1.11%

ATHA 5.94%

ATHE 1.12%

ATHX -33.50%

ATNF 0.99%

ATOS 2.91%

ATRA -2.89%

ATXI 1.93%

ATXS -1.00%

AUPH -1.17%

AURA -0.15%

AUTL -1.72%

AVBP -2.86%

AVEO 0.00%

AVIR -0.15%

AVRO -1.41%

AVTE -5.17%

AVTX -1.25%

AVXL -2.71%

AXLA 0.00%

AXSM -1.75%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO 0.81%

BCAB 3.59%

BCDA -2.07%

BCDAW -41.77%

BCEL 0.00%

BCLI 7.14%

BCRX 1.15%

BCTX 7.61%

BCTXW -16.32%

BCYC 0.83%

BDRX -3.52%

BDTX -0.85%

BEAM 0.25%

BFRA -2.91%

BGNE -2.59%

BIOR -3.40%

BIVI 1.27%

BLCM -6.68%

BLI -5.88%

BLPH 0.00%

BLRX -0.85%

BLTE -0.62%

BLU 0.03%

BLUE -0.53%

BMEA -9.96%

BMRN 0.35%

BNOX -2.22%

BNTC -2.11%

BNTX -1.58%

BOLD -7.90%

BOLT 1.31%

BPMC -1.27%

BPTH 1.86%

BPTS -13.47%

BRNS -0.74%

BRTX -2.36%

BTAI 23.31%

BTTX 53.33%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI 3.33%

CABA 0.76%

CADL -0.97%

CALA 0.00%

CALC -1.77%

CALT -0.59%

CAPR -2.80%

CARA 0.21%

CARM 12.13%

CASI -1.67%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS -6.90%

CCCC -5.41%

CCXI 0.00%

CDAK 0.00%

CDIO -2.02%

CDIOW 24.00%

CDMO -3.10%

CDMOP 0.04%

CDT -10.57%

CDTTW -39.60%

CDTX -1.92%

CDXC 0.00%

CDXS 4.83%

CELC -4.25%

CELU -1.50%

CELUW 11.80%

CERC -1.68%

CERE -0.91%

CERO -3.40%

CEROW -10.18%

CFRX -27.95%

CGEM -2.50%

CGEN -2.79%

CGON -0.29%

CGTX -5.11%

CHMA -6.00%

CHRS -0.32%

CINC 0.00%

CING 2.56%

CINGW 34.95%

CKPT -2.88%

CLBS -16.75%

CLDX -2.26%

CLGN 0.34%

CLLS -4.15%

CLNN 2.42%

CLNNW 0.00%

CLRB 7.02%

CLSD 1.60%

CLSN -0.68%

CLVS 0.00%

CMMB -0.01%

CMND 3.63%

CMPI 0.00%

CMPX -8.03%

CMRA 0.00%

CMRAW 33.33%

CMRX -2.71%

CNCE 0.00%

CNSP -40.05%

CNST 0.00%

CNTA -0.67%

CNTB -2.25%

CNTX -6.85%

COCP -2.02%

COEPW 32.45%

COGT -2.91%

CORT 2.31%

COYA -1.46%

CPRX -0.86%

CRBP -1.88%

CRBU -4.83%

CRDF -1.77%

CRGX 1.28%

CRIS -0.38%

CRNX -5.66%

CRSP 0.89%

CRTX 2.63%

CRVO -2.50%

CRVS 1.12%

CSBR -1.59%

CTCX -1.63%

CTIC 0.06%

CTMX -3.31%

CTNM -0.65%

CTXR 0.04%

CUE 3.81%

CVAC -2.26%

CVKD -5.23%

CWBR 2.80%

CYAD -12.96%

CYCC 9.75%

CYCCP 5.49%

CYCN 0.43%

CYT -2.27%

CYTK -2.00%

CYTO -2.73%

DARE 7.54%

DAWN 0.52%

DBTX -0.81%

DBVT 4.44%

DFFN 10.28%

DICE 0.06%

DMAC 32.19%

DNLI -1.61%

DNTH -6.31%

DOMH -1.58%

DRMA -1.10%

DRMAW -1.25%

DRNA 0.00%

DRTS 1.85%

DRTSW 0.00%

DRUG 0.95%

DSGN -1.51%

DTIL 1.36%

DYAI 9.68%

EARS -1.77%

EDIT -2.51%

EDSA -1.00%

EFTR 8.18%

EFTRW -51.85%

EIGR -9.21%

ELAB -1.00%

ELDN 7.98%

ELEV -4.77%

ELOX 7.69%

ELTX -0.88%

ELVN -3.87%

ELYM 1.05%

ENGN 1.67%

ENGNW 0.12%

ENLV 2.54%

ENOB 1.79%

ENSC 5.11%

ENTA -0.49%

ENTO -4.42%

ENTX 0.69%

ENVB 1.10%

EPIX -0.10%

EPRX -2.97%

EPZM 0.00%

EQ 0.86%

EQRX -2.09%

EQRXW 0.00%

ERAS -1.20%

ERNA 0.00%

ERYP 1.30%

ESLA 4.30%

ESLAW 87.05%

ETNB -0.83%

ETON 1.68%

ETTX 0.00%

EVAX -2.14%

EVGN 3.88%

EVLO 0.00%

EWTX -0.06%

EXAI -0.94%

EXEL -0.36%

EYEG -0.69%

EYEN 1.48%

EYPT -0.12%

FATE -7.93%

FBIO 0.59%

FBIOP 0.92%

FBLG -15.20%

FBRX -0.04%

FDMT -4.86%

FENC -1.29%

FGEN -5.53%

FHTX 1.43%

FIXX 0.77%

FMTX 0.00%

FNCH 8.87%

FOLD -2.58%

FREQ 4.76%

FRLN 0.15%

FRTX 0.00%

FSTX 0.00%

FTRE -0.31%

FULC -3.18%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT -6.29%

GANX -1.49%

GBIO -2.12%

GBT 0.01%

GDTC 0.50%

GERN -4.20%

GHRS -1.59%

GLMD -2.32%

GLPG -2.26%

GLSI 2.80%

GLTO -0.57%

GLUE -1.58%

GLYC -10.03%

GMAB -0.43%

GMDA -18.25%

GMTX 0.00%

GNCA -85.71%

GNFT -0.52%

GNLX 1.33%

GNPX 0.00%

GNTA 3.94%

GOSS -9.86%

GOVX 4.99%

GOVXW -49.04%

GPCR -6.49%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS -0.08%

GRTX 0.00%

GTHX 0.68%

GUTS -5.31%

GXGXW 41.67%

GYRE -7.16%

HALO -0.89%

HARP 0.09%

HCWB -3.75%

HEPA 2.80%

HGEN -84.62%

HILS 5.66%

HLVX -0.77%

HOOK 1.13%

HOTH -2.70%

HOWL -2.14%

HRMY 0.85%

HRTX 1.80%

HSTO 0.00%

HUMA 2.13%

HUMAW -0.01%

IBRX -4.47%

ICCC 0.22%

ICPT 0.21%

ICU 16.82%

ICUCW 20.20%

ICVX -0.91%

IDRA -23.04%

IDYA -1.52%

IFRX -1.85%

IGMS -0.15%

IKNA 0.60%

IKT 1.42%

IMAB -0.58%

IMCR -2.61%

IMGN 0.02%

IMGO 0.00%

IMMP 4.55%

IMMX -6.90%

IMNM -1.56%

IMNN 0.88%

IMPL -27.27%

IMRA 15.96%

IMRN -1.18%

IMRX -0.70%

IMTX -1.58%

IMTXW 6.00%

IMUX 1.56%

IMV 0.00%

IMVT -3.66%

INAB 0.00%

INBX 0.46%

INCY -0.95%

INDP 11.07%

INFI -52.38%

INKT -0.01%

INM -2.20%

INMB 2.66%

INO -1.82%

INSM -0.85%

INTS -2.75%

INVA 0.25%

INZY 1.14%

IOBT -11.42%

IONS 0.34%

IOVA -2.31%

IPA 2.46%

IPHA 5.58%

IPSC -1.95%

IRON -2.81%

ISEE 0.38%

ITOS -1.44%

ITRM 1.67%

IVA 6.96%

IVVD -4.13%

JAGX 1.04%

JANX -4.02%

JAZZ -0.51%

JNCE 0.00%

JSPR -5.92%

JSPRW 20.88%

JUNS 0.00%

JUNSW 0.00%

KA -3.94%

KALV -1.90%

KDNY 0.22%

KMPH -0.34%

KNSA -2.71%

KNTE -0.38%

KOD -6.72%

KPRX 0.96%

KPTI -1.38%

KRBP -10.00%

KRON 1.05%

KROS -1.20%

KRRO -6.34%

KRTX 0.03%

KRYS -0.99%

KTRA 16.95%

KTTA 8.16%

KTTAW 0.92%

KURA -1.83%

KYMR -2.34%

KYTX -3.94%

KZIA 5.16%

KZR -1.49%

LABP 0.57%

LBPH -1.71%

LBPS 0.00%

LBPSW 14.81%

LEGN 1.49%

LENZ -4.01%

LEXX 0.00%

LEXXW -14.63%

LGND -1.30%

LGNDV 0.00%

LGVN -10.05%

LIAN -8.28%

LIFE 2.70%

LIPO -7.10%

LIXT -5.24%

LIXTW 63.57%

LJPC -0.32%

LMNL 0.12%

LOGC 0.70%

LPCN -3.16%

LPTX -1.10%

LQDA -0.24%

LRMR -1.78%

LSTA -4.06%

LTRN 1.76%

LUMO -1.32%

LVTX 0.00%

LXEO -4.33%

LXRX -2.35%

LYEL -35.13%

LYRA 2.33%

MACK 0.10%

MBIO -9.36%

MBRX -1.72%

MCRB 1.37%

MDGL -2.42%

MDNA -13.16%

MDWD 0.10%

MDXG -2.58%

MEIP -0.13%

MESO -1.78%

MGNX -3.03%

MGTA -7.74%

MGTX -2.97%

MGX -2.68%

MIRM -1.55%

MIRO 0.59%

MIST 1.54%

MITO 0.00%

MLEC -7.69%

MLECW 2.31%

MLND -5.36%

MLTX -0.63%

MLYS -5.67%

MNKD -1.05%

MNMD 0.21%

MNOV 2.11%

MNPR -5.01%

MOLN 0.28%

MOR 1.06%

MORF -3.74%

MREO -4.14%

MRKR 2.68%

MRNA -4.99%

MRNS -4.04%

MRSN -2.62%

MRTX -0.17%

MRUS 0.14%

MRVI -1.82%

MTCR -1.29%

MTEM 4.46%

MTP -18.50%

MURA -1.24%

MYMD 8.38%

NAMS 1.37%

NAMSW 0.43%

NAUT 1.14%

NBRV 0.71%

NBSE -1.56%

NBTX 8.61%

NCNA 1.09%

NERV -1.87%

NEXI 2.60%

NGM -1.28%

NGNE -2.03%

NKGN 5.88%

NKGNW 8.00%

NKTR -4.21%

NKTX -4.57%

NLSP -2.82%

NLSPW 26.67%

NMRA -0.91%

NMTR -42.97%

NOVN -24.84%

NRBO 12.11%

NRIX -0.29%

NRSN -7.05%

NRSNW 0.00%

NRXP -4.14%

NRXPW 18.33%

NRXS 4.82%

NTBL 5.06%

NTEC -12.45%

NTHI 0.00%

NTLA -6.21%

NTRBW -31.07%

NUVL -2.00%

NVAX -2.29%

NVCT 3.59%

NVIV -34.28%

NXTC -2.94%

NYMX -0.05%

OABI 0.26%

OABIW -10.06%

OBIO -2.99%

OBSV 0.00%

OCEA 0.00%

OCGN 4.26%

OCS -1.02%

OCUL -1.91%

OCUP 1.96%

ODT -4.27%

OKYO 1.51%

OLMA -5.54%

OMER -1.03%

OMGA 4.96%

ONCO 5.04%

ONCR -3.08%

ONCS 31.87%

ONCT -1.87%

ONCY 0.99%

ONTX -0.47%

ONVO 0.99%

OPNT 0.00%

OPT 3.09%

ORGS -2.07%

ORIC -3.56%

ORMP 15.09%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK -1.81%

OVID -1.43%

OYST 0.00%

PALI -0.87%

PASG -1.30%

PBLA -7.50%

PBM -7.64%

PBYI 1.69%

PCSA 0.00%

PCVX -0.37%

PDSB -1.27%

PEPG -0.60%

PGEN -2.99%

PHAR 1.51%

PHAS 0.00%

PHAT -1.06%

PHIO -3.57%

PHIOW 36.47%

PHVS -7.22%

PHXM -5.20%

PIRS 0.58%

PKBO 0.00%

PKBOW 999 900.00%

PLRX -0.73%

PLUR 6.01%

PMN 0.72%

PMVP -1.19%

PNT 0.16%

PPBT -4.26%

PRAX 0.84%

PRDS 0.93%

PRLD 0.00%

PROG -3.47%

PROK 0.22%

PRQR -0.01%

PRTA -2.31%

PRTC 0.49%

PRTG -0.50%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV -5.11%

PSTX -0.97%

PTCT -0.50%

PTE -0.82%

PTGX -1.70%

PTIXW -49.04%

PULM 2.60%

PXMD 0.00%

PYPD 0.07%

PYXS 2.29%

QLGN -3.72%

QNCX 5.70%

QNRX 0.37%

QSI -11.92%

QSIAW -3.13%

QTTB -4.54%

QURE -0.22%

RAIN -1.63%

RANI 6.42%

RAPT -2.27%

RARE 1.10%

RCKT -8.29%

REGN -0.70%

RENB -3.42%

REPL -2.83%

RETA 0.02%

REUN -0.89%

REVB -1.40%

REVBU 3.46%

REVBW 4.38%

RGLS -4.91%

RGNX -5.40%

RIGL -3.28%

RLAY -4.60%

RLMD 0.33%

RLYB -0.34%

RNA -0.46%

RNAC -5.65%

RNAZ -0.96%

RNXT 1.88%

ROIV -2.08%

ROIVW 4.56%

RPHM 0.00%

RPRX 0.28%

RPTX -2.93%

RUBY 2.70%

RVLP -32.05%

RVMD -1.08%

RVMDW -30.00%

RVNC 1.70%

RVPH -1.58%

RVPHW 1.62%

RXDX 0.09%

RXRX -3.36%

RYTM -6.46%

RYZB 0.02%

RZLT 1.69%

SABS -1.37%

SABSW -11.81%

SAGE 1.56%

SANA -3.97%

SAVA -0.26%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI 5.50%

SCPH -0.51%

SCPS 0.00%

SEEL -4.48%

SEER 0.00%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO -1.03%

SGMT -1.93%

SGTX -2.56%

SIOX 22.63%

SLDB -7.07%

SLGL 4.00%

SLN -4.21%

SLNO -3.74%

SLRX 6.69%

SLS -2.99%

SMMT -2.56%

SNDX 0.84%

SNGX -3.02%

SNPX -0.81%

SONN -1.08%

SPPI -0.49%

SPRB 0.32%

SPRC -4.17%

SPRO 0.30%

SRNE -34.00%

SRPT -1.81%

SRRA 0.00%

SRRK -2.60%

SRZN -2.45%

STAB 0.00%

STOK -5.06%

STRO -2.84%

STSA 0.00%

STTK -4.78%

SURF -0.93%

SVRA -3.16%

SWTX 0.26%

SYBX -1.94%

SYRS -1.72%

TALS -0.73%

TARA -6.90%

TARS 0.12%

TBPH 0.48%

TCBP 2.73%

TCDA 0.00%

TCON -2.03%

TCRR 0.00%

TCRT 1.59%

TCRX 2.58%

TECH -0.23%

TENX -1.27%

TERN -7.70%

TFFP -3.05%

TGTX -2.94%

THRX 0.12%

TIL -0.20%

TLC 0.00%

TLSA -4.13%

TNGX -2.16%

TNXP -6.39%

TNYA -8.23%

TPST 2.43%

TRDA -3.86%

TRVI 1.15%

TRVN 2.92%

TSHA -24.34%

TSVT -3.45%

TTNP -9.27%

TVTX 0.63%

TYRA -7.09%

UBX -2.12%

UNCY -3.73%

URGN -1.46%

UTHR -0.32%

VACC 11.36%

VALN -2.89%

VAXX 99.94%

VBIV 0.78%

VBLT -8.77%

VCEL -0.09%

VCNX 10.35%

VCYT -1.28%

VERA -2.81%

VERU 0.79%

VERV -3.06%

VIGL 5.11%

VINC 1.62%

VIR 0.06%

VIRI -1.57%

VIRX 2.40%

VKTX -1.63%

VLON -13.04%

VNDA -2.12%

VOR -2.02%

VRCA -0.07%

VRDN -4.31%

VRNA -1.40%

VRPX 0.38%

VRTX 0.35%

VSTM -3.74%

VTGN -0.45%

VTVT -2.97%

VTYX -0.21%

VXRT -2.59%

VYGR -1.66%

VYNE -3.47%

VYNT 7.78%

WINT -3.24%

WVE -4.40%

XBIO 0.93%

XBIT 1.77%

XCUR 3.58%

XENE -3.11%

XERS 2.62%

XFOR 3.13%

XLO 2.00%

XLRN 0.00%

XNCR 0.47%

XOMA -3.14%

XOMAO 0.36%

XOMAP -0.82%

XRTX -8.92%

YMAB -1.80%

ZGNX 0.00%

ZIOP -0.88%

ZLAB -3.51%

ZNTL -2.74%

ZSAN 0.00%

Insider Trading

Date	Person	Action	Amount	type
2023-11-28	Wiggans Thomas G	Buy	10 000	Voting Common Stock
2023-11-21	Wiggans Thomas G	Buy	10 000	Voting Common Stock
2023-11-20	Wiggans Thomas G	Buy	10 000	Voting Common Stock
2023-11-17	Wiggans Thomas G	Buy	10 000	Voting Common Stock
2023-11-16	Wiggans Thomas G	Buy	10 000	Voting Common Stock

INSIDER POWER
90.52
Last 82 transactions
Buy: 29 502 185 \| Sell: 1 800 772

सहसंबंध (AI algo v.1.1b): Overvalued: -0.07% $0.200 paired level. (एल्गो वास्तविक समय में सबसे अधिक सहसंबंधित स्टॉक्स के परिवर्तनों का ट्रैक करता है और तत्काल अद्यतन देता है)

Jasper Therapeutics, Inc. सहसंबंध

10 सबसे अधिक सकारात्मक सहसंबंध

10 सबसे अधिक नकारात्मक सहसंबंध

क्या आप जानते हैं?

कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।

कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।

Jasper Therapeutics, Inc. वित्तीय

Annual	2023
राजस्व:	$0
सकल लाभ:	$-1.11M (0.00 %)
EPS:	$-6.18

FY	2023
राजस्व:	$0
सकल लाभ:	$-1.11M (0.00 %)
EPS:	$-6.18

FY	2022
राजस्व:	$0
सकल लाभ:	$-1.31M (0.00 %)
EPS:	$-6.63

FY	2021
राजस्व:	$0.00
सकल लाभ:	$0.00 (0.00 %)
EPS:	$0

Financial Reports:

No articles found.

Jasper Therapeutics, Inc. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Jasper Therapeutics, Inc.

Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. It focuses on the development and commercialization of therapeutic agents for diseases, such as chronic spontaneous urticaria, lower to intermediate risk myelodysplastic syndrome, and novel conditioning regimens for stem cell transplantation and ex-vivo gene therapy, a technique in which genetic manipulation of cells is performed outside of the body prior to transplantation. The company\'s lead product candidate is briquilimab, which is in clinical development as a novel therapeutic antibody that clears hematopoietic stem cells from bone marrow in patients prior to undergoing allogeneic stem cell therapy or stem cell gene therapy. It is also developing engineered hematopoietic stem cells product candidates to overcome key limitations of allogeneic and autologous gene-edited stem cell grafts. The company is headquartered in Redwood City, California.